Guo X, Chen L J, Buda M, Jin G Z
Shanghai Institute of Materia Medica, Chinese Academy of Sciences.
Zhongguo Yao Li Xue Bao. 1992 Jul;13(4):289-92.
l-Stepholidine (SPD) 2.5 and haloperidol (Hal) 1.0 mg.kg-1 ip increased rat striatal L-3,4-dihydroxyphenylalanine (DOPA) and 3,4-dihydroxyphenylacetic acid (DOPAC) accumulation induced by NSD 1015 (50 mg.kg-1, ip), a decarboxylase inhibitor. SPD (2.5 mg.kg-1, ip) did not alter but apomorphine (2.0 mg.kg-1, ip) decreased the dopamine (DA) content elevated by gamma-butyrolactone (GBL, 750 mg.kg-1, ip) in the rat striatum. Ip injection of either SPD 5.0 or Hal 2.5 mg.kg-1 after NSD 1015 50 mg.kg-1 or NSD 1015 plus GBL 750 mg.kg-1 also augmented tyrosine hydroxylase (TH) activity in the rat striatum. These results suggest that SPD produces an antagonistic effect on presynaptic DA receptors.
左旋千金藤啶碱(SPD)2.5毫克及氟哌啶醇(Hal)1.0毫克·千克⁻¹腹腔注射可增加由脱羧酶抑制剂NSD 1015(50毫克·千克⁻¹,腹腔注射)诱导的大鼠纹状体L-3,4-二羟基苯丙氨酸(DOPA)和3,4-二羟基苯乙酸(DOPAC)的蓄积。SPD(2.5毫克·千克⁻¹,腹腔注射)未改变,但阿扑吗啡(2.0毫克·千克⁻¹,腹腔注射)降低了由γ-丁内酯(GBL,750毫克·千克⁻¹,腹腔注射)升高的大鼠纹状体多巴胺(DA)含量。在NSD 1015 50毫克·千克⁻¹或NSD 1015加GBL 750毫克·千克⁻¹后腹腔注射SPD 5.0毫克或Hal 2.5毫克·千克⁻¹也增强了大鼠纹状体酪氨酸羟化酶(TH)的活性。这些结果表明SPD对突触前DA受体产生拮抗作用。